Proportion of isolates with resistance to ciprofloxacin reported to in New Zealand
New Zealand: Proportion of isolates with resistance to ciprofloxacin reported to was 18.02 in 2017. ▼ Falling
Latest (2017)
18.02
Change on year
down 24.3%
World rank
52nd
of 54 countries
All-time high
60.04
in 2015
All-time low
18.02
in 2017
Years of data
9
2009–2017
Proportion of isolates with resistance to ciprofloxacin reported to in New Zealand, 2009–2017
Source: World Health Organization, Global Health Observatory.
Analysis
New Zealand recorded 18.02 for proportion of isolates with resistance to ciprofloxacin reported to in 2017. That is the lowest value across all 9 years on record.
The figure is down 24.3% on the previous year and down 48.6% over ten years.
Over the whole period, proportion of isolates with resistance to ciprofloxacin reported to in New Zealand peaked at 60.04 in 2015 and was at its lowest, 18.02, in 2017.
New Zealand ranks 52nd of 54 countries on this measure, in the bottom quarter.
Proportion of isolates with resistance to ciprofloxacin reported to in New Zealand, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 35.04 | — |
| 2010 | 29.17 | -16.8% |
| 2011 | 45.11 | +54.7% |
| 2012 | 41.74 | -7.5% |
| 2013 | 35.42 | -15.1% |
| 2014 | 47.34 | +33.7% |
| 2015 | 60.04 | +26.8% |
| 2016 | 23.82 | -60.3% |
| 2017 | 18.02 | -24.3% |
New Zealand compared with similar countries
- New Zealand's 18.02 is below the median for high income countries, which is 55.25, 33% of the median. (34 countries reporting)
- New Zealand's 18.02 is below the median for East Asia & Pacific, which is 83.67, 22% of the median. (13 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 35.04 | 35.04 | 35.04 | 1 |
| 2010s | 37.58 | 18.02 | 60.04 | 8 |
Countries ranked near New Zealand
- 49 Portugal 32.8 compare
- 50 United States of America 31.22 compare
- 51 Australia 25.89 compare
- 53 Fiji 1.96 compare
- 54 Russian Federation 0 compare
More health data for New Zealand
- Un projection of annual infant deaths, annual growth rate -2.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4815 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,116 deaths per 1,000 people (2090)
- Number of infants who die before age 1 33 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.1187 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0277 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.018 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with resistance to ciprofloxacin reported to in New Zealand?
- Proportion of isolates with resistance to ciprofloxacin reported to in New Zealand was 18.02 in 2017, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to ciprofloxacin reported to recorded in New Zealand?
- The highest recorded value was 60.04 in 2015.
- What is the lowest proportion of isolates with resistance to ciprofloxacin reported to recorded in New Zealand?
- The lowest recorded value was 18.02 in 2017.
- How does New Zealand rank for proportion of isolates with resistance to ciprofloxacin reported to?
- New Zealand ranks 52nd out of 54 countries with data for 2017.
- Is proportion of isolates with resistance to ciprofloxacin reported to rising or falling in New Zealand?
- Over the last ten years it is down 48.6%. The long-run trend across the full record is falling.
- Where does this New Zealand data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).